Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dynavax Technologies Corporation - Common Stock (NQ: DVAX )

13.74 -0.05 (-0.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,878,898
Open 13.74
Bid (Size) 13.74 (1)
Ask (Size) 14.41 (1)
Prev. Close 13.79
Today's Range 13.65 - 13.89
52wk Range 9.740 - 14.63
Shares Outstanding 128,489,060
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors
From Deep Track Capital, LP
Via Business Wire
Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings)
Via Benzinga

Performance

YTD
+6.51%
+6.51%
1 Month
+4.09%
+4.09%
3 Month
+6.43%
+6.43%
6 Month
+25.94%
+25.94%
1 Year
+8.70%
+8.70%

More News

Read More
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Scheduled For February 20, 2025
Via Benzinga
Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies’ Board of Directors at 2025 Annual Meeting
From Deep Track Capital, LP
Via Business Wire
Insights into Dynavax Technologies's Upcoming Earnings
Via Benzinga
Assessing Dynavax Technologies: Insights From 4 Financial Analysts
Via Benzinga
Dynavax Technologies: Q4 Earnings Insights
Via Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 15
Via Talk Markets
Topics Stocks / Equities
Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
Via Benzinga
This Columbus McKinnon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Dynavax Technologies (DVAX) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)
From Glancy Prongay & Murray LLP
Via Business Wire
Earnings Preview For Dynavax Technologies
Via Benzinga
Lantheus Appoints Julie Eastland as New Board Member
From Lantheus Holdings, Inc.
Via GlobeNewswire
Dynavax Technologies (DVAX) Q2 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DVAX Stock Earnings: Dynavax Technologies Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
Via Benzinga
Exposures Product Safety
Dynavax Technologies (DVAX) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
DVAX Stock Earnings: Dynavax Technologies Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Dynavax Technologies (DVAX) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Vera Therapeutics Stock Soared by 22% This Week
Via The Motley Fool
3 Stocks Set to Soar 68% to 200% Higher
Via InvestorPlace
Dynavax Technologies (DVAX) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.